Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Circ Heart Fail. 2010 Nov 19;4(1):65–70. doi: 10.1161/CIRCHEARTFAILURE.110.955013

Table 4.

Gene Expression in Normal dogs, Untreated Heart failure Control Dogs and Heart failure Dogs Treated with Chronic Carotid Sinus Baroreflex (CSB) Activation

Normal
(n=6)
Control
(n=6)
CSB Activation
(n=8)
GADPH (du) 0.34 ± 0.02 0.35 ± 0.03 0.36 ± 0.02
β1-Adrenergic Receptor (du) 0.55 ± 0.06 0.26 ± 0.04* 0.51 ± 0.08
β2-Adrenergic Receptor (du) 0.23 ± 0.03 0.26 ± 0.04 0.25 ± 0.03
β-Adrenergic Receptor Kinase (du) 0.27 ± 0.05 1.22 ± 0.08* 0.54 ± 0.06*
Adenylyl Cyclase (du) 0.64 ± 0.05 0.34 ±0.04* 0.53 ± 0.06*
Angiotensinogen (du) 0.36 ± 0.05 0.74 ± 0.06* 0.39 ± 0.03
eNOS (du) 0.71 ± 0.07 0.44 ± 0.07* 0.56 ± 0.07*
iNOS (du) 0.34 ± 0.06 0.72 ± 0.06* 0.43 ± 0.05*

GADPH = glyceraldehyde-3-phosphate dehydrogenase ; eNOS = endothelial nitric oxide synthase. iNOS – inducible nitric oxide synthase ;

*

=p<0.05 vs. Normal,

=p<0.05 vs. Control.